公司资料
Sage Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- SAGE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SAGE.
公司概览
业务概览
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Sage sits in specialty neuroscience biotech.
商业模式特征
The company combines commercial execution around CNS medicines with ongoing development in brain-health programs.
生物医药行业定位
Sage is a CNS catalyst name whose stock tends to move sharply on clinical, commercial, and partnership developments.
未来催化剂
- Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset. The stock remains highly sensitive to whether the launch base can stabilize.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。